Antidiabetic Plants for Drug Discovery: Pharmacology, Secondary Metabolite Profiling, and Ingredients with Insulin Mimetic Activity

This volume explores the pharmacological potential of 11 important antidiabetic plants, examining their antihyperglycemic, hypoglycemic, and anti-lipidemic properties, and discussing current genome editing research perspectives. It highlights the therapeutic aspects, active antidiabetic compounds, and genome editing technology associated with these plants, including Azadirachta indica, Gymnema sylvestre, Syzygium cumini, Ceylon cinnamon, insulin plant, Trigonella foenum-graecum, Mulberry, Nigella sativa L., Aegle marmelos, Ficus benghalensis, and garlic.

Format: Hardback
Length: 324 pages
Publication date: 29 December 2022
Publisher: Apple Academic Press Inc.

This comprehensive volume delves into the potential pharmacological applications of 11 significant antidiabetic plants, exploring their antihyperglycemic, hypoglycemic, and anti-lipidemic properties alongside current perspectives on genome editing research. Plant natural products, known as phytoconstituents, hold immense promise as candidates for antidiabetic pharmacological actions. These phytoconstituents, including fl avonoids, terpenoids, saponins, carotenoids, alkaloids, and glycosides, play pivotal roles in the ongoing and future development of potent antidiabetic drugs.

Within each chapter, a specific plant with antidiabetic properties is examined in detail. The therapeutic aspects, active antidiabetic compounds, and relevant genome editing technologies are explored, providing a comprehensive understanding of these plants' potential for drug discovery. The plants discussed in this volume include:

Azadirachta indica (commonly known as neem, nimtree, or Indian lilac).
Gymnema sylvestre (commonly called gymnema, Australian cowplant, and Periploca of the woods).
Syzygium cumini (commonly known as Malabar plum, Java plum, black plum, jamun, or jambolana).
Ceylon cinnamon (or true cinnamon, distinct from cassia cinnamon).
Insulin plant (or Costus pictus).
Trigonella foenum-graecum (better known as fenugreek).
Mulberry.
Nigella sativa L. (black caraway, also known as black cumin, nigella, kalojeera, kalonji, or kalanji).
Aegle marmelos (L.) (commonly known as bael (or bili or bhel), also Bengal quince, golden apple, Japanese bitter orange, stone apple, or wood apple).
Ficus benghalensis (the banyan, banyan fig, and Indian banyan).
Garlic (Allium sativum).

Antidiabetic Plants for Drug Discovery: Pharmacology, Secondary Metabolite Profiling, and Ingredients with Insulin Mimetic Activity serves as a valuable resource for students, drug researchers, medical practitioners, diabetic patients, and a wide range of individuals interested in the field of antidiabetic research and treatment. By comprehensively reviewing the pharmacological properties, active compounds, and genome editing technologies associated with these plants, this book offers insights into the potential for developing innovative and effective antidiabetic therapies.

Weight: 789g
Dimension: 229 x 152 (mm)
ISBN-13: 9781774910061